|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Westdorp H, Sköld AE, Snijer BA, Franik S,
Mulder SF, Major PP, Foley R, Gerritsen WR and de Vries IJ:
Immunotherapy for prostate cancer: Lessons from responses to
tumor-associated antigens. Front Immunol. 5:1912014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lowes LE, Goodale D, Xia Y, Postenka C,
Piaseczny MM, Paczkowski F and Allan AL: Epithelial-to-mesenchymal
transition leads to disease-stage differences in circulating tumor
cell detection and metastasis in pre-clinical models of prostate
cancer. Oncotarget. 7:76125–76139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tahara E: Molecular aspects of invasion
and metastasis of stomach cancer. Verh Dtsch Ges Pathol. 84:43–49.
2000.PubMed/NCBI
|
|
5
|
McConnell BB and Yang VW: Mammalian
Krüppel-like factors in health and diseases. Physiol Rev.
90:1337–1381. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen YJ, Wu CY, Chang CC, Ma CJ, Li MC and
Chen CM: Nuclear Krüppel-like factor 4 expression is associated
with human skin squamous cell carcinoma progression and metastasis.
Cancer Biol Ther. 7:777–782. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fadous-Khalifé MC, Aloulou N, Jalbout M,
Hadchity J, Aftimos G, Paris F and Hadchity E: Krüppel-like factor
4: A new potential biomarker of lung cancer. Mol Clin Oncol.
5:35–40. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang W, Chen X, Kato Y, Evans PM, Yuan S,
Yang J, Rychahou PG, Yang VW, He X, Evers BM, et al: Novel cross
talk of Krüppel-like factor 4 and beta-catenin regulates normal
intestinal homeostasis and tumor repression. Mol Cell Biol.
26:2055–2064. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dang DT, Pevsner J and Yang VW: The
biology of the mammalian Krüppel-like family of transcription
factors. Int J Biochem Cell Biol. 32:1103–1121. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Black AR, Black JD and Azizkhan-Clifford
J: Sp1 and Krüppel- like factor family of transcription factors in
cell growth regulation and cancer. J Cell Physiol. 188:143–160.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaczynski J, Cook T and Urrutia R: Sp1 and
Krüppel-like transcription factors. Genome Biol. 4:2062003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen X, Johns DC, Geiman DE, Marban E,
Dang DT, Hamlin G, Sun R and Yang VW: Krüppel-like factor 4
(gut-enriched Krüppellike factor) inhibits cell proliferation by
blocking G1/S progression of the cell cycle. J Biol Chem.
276:30423–30428. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang J, Chan YS, Loh YH, Cai J, Tong GQ,
Lim CA, Robson P, Zhong S and Ng HH: A core KLF circuitry regulates
self-renewal of embryonic stem cells. Nat Cell Biol. 10:353–360.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang P, Andrianakos R, Yang Y, Liu C and
Lu W: Krüppel-like factor 4 (Klf4) prevents embryonic stem (ES)
cell differentiation by regulating Nanog gene expression. J Biol
Chem. 285:9180–9189. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao W, Hisamuddin IM, Nandan MO, Babbin
BA, Lamb NE and Yang VW: Identification of Krüppel-like factor 4 as
a potential tumor suppressor gene in colorectal cancer. Oncogene.
23:395–402. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang N, Liu ZH, Ding F, Wang XQ, Zhou CN
and Wu M: Downregulation of gut-enriched Krüppel-like factor
expression in esophageal cancer. World J Gastroenterol. 8:966–970.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Foster KW, Ren S, Louro ID, Lobo-Ruppert
SM, McKie-Bell P, Grizzle W, Hayes MR, Broker TR, Chow LT and
Ruppert JM: Oncogene expression cloning by retroviral transduction
of adenovirus E1A-immortalized rat kidney RK3E cells:
Transformation of a host with epithelial features by c-Myc and the
zinc finger protein GKLF. Cell Growth Differ. 10:423–434.
1999.PubMed/NCBI
|
|
18
|
Wei D, Gong W, Kanai M, Schlunk C, Wang L,
Yao JC, Wu TT, Huang S and Xie K: Drastic down-regulation of
Krüppel-like factor 4 expression is critical in human gastric
cancer development and progression. Cancer Res. 65:2746–2754. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li D, Peng Z, Tang H, Wei P, Kong X, Yan
D, Huang F, Li Q, Le X, Li Q, et al: KLF4-mediated negative
regulation of IFITM3 expression plays a critical role in colon
cancer pathogenesis. Clin Cancer Res. 17:3558–3568. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi M, Cui J, Du J, Wei D, Jia Z, Zhang J,
Zhu Z, Gao Y and Xie K: A novel KLF4/LDHA signaling pathway
regulates aerobic glycolysis in and progression of pancreatic
cancer. Clin Cancer Res. 20:4370–4380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Place RF, Huang V, Wang X, Noonan
EJ, Magyar CE, Huang J and Li LC: Prognostic value and function of
KLF4 in prostate cancer: RNAa and vector-mediated overexpression
identify KLF4 as an inhibitor of tumor cell growth and migration.
Cancer Res. 70:10182–10191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee HK, Lee DS and Park JC: Nuclear factor
I-C regulates E-cadherin via control of KLF4 in breast cancer. BMC
Cancer. 15:1132015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mohler J, Bahnson RR, Boston B, Busby JE,
D'Amico A, Eastham JA, Enke CA, George D, Horwitz EM, Huben RP, et
al: NCCN clinical practice guidelines in oncology: Prostate cancer.
J Natl Compr Canc Netw. 8:162–200. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang N, Zhang J, Shuai L, Zha L, He M,
Huang Z and Wang Z: Krüppel-like factor 4 negatively regulates
β-catenin expression and inhibits the proliferation, invasion and
metastasis of gastric cancer. Int J Oncol. 40:2038–2048.
2012.PubMed/NCBI
|
|
25
|
Wanger RT, Xu X, Yi F, Merrill BJ and
Coony AJ: Canonical Wnt/β-catenin regulation of liver receptor
homolog-1 mediates pluripotency gene expression. Stem Cells.
28:1794–1804. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Basang Z, Ding H, Lu Z, Ning T, Wei
H, Cai H and Ke Y: Latexin expression is downregulated human
gastric carcinomas and exhibits tumor suppressor potential. BMC
Cancer. 11:1212011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shaheen FS, Znojek P, Fisher A, Webster M,
Plummer R, Gaughan L, Smith GC, Leung HY, Curtin NJ and Robson CN:
Targeting the DNA double strand break repair machinery in prostate
cancer. PLoS One. 6:e203112011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ganesan K, Ivanova T, Wu Y, Rajasegaran V,
Wu J, Lee MH, Yu K, Rha SY, Chung HC, Ylstra B, et al: Inhibition
of gastric cancer invasion and metastasis by PLA2G2A, a
novel beta-catenin/TCF target gene. Cancer Res. 68:4277–4286. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yori JL, Johnson E, Zhou G, Jain MK and
Keri RA: Krüppel-like factor 4 inhibits epithelial-to-mesenchymal
transition through regulation of E-cadherin gene expression. J Biol
Chem. 285:16854–16863. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang P, Hong H, Sun X, Jiang H, Ma S,
Zhao S, Zhang M, Wang Z, Jiang C and Liu H: MicroRNA-10b regulates
epithelial-mesenchymal transition by modulating
KLF4/Notch1/E-cadherin in cisplatin-resistant nasopharyngeal
carcinoma cells. Am J Cancer Res. 6:141–156. 2016.PubMed/NCBI
|
|
32
|
Miller IJ and Bieker JJ: A novel,
erythroid cell-specific murine transcription factor that binds to
the CACCC element and is related to the Krüppel family of nuclear
proteins. Mol Cell Biol. 13:2776–2786. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yoshida T and Hayashi M: Role of
Kruppel-likefactor4 and its binding proteins in vascular disease. J
Atheroscler Thromb. 21:402–413. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qin S and Zhang CL: Role of Krüppel-like
factor 4 in neurogenesis and radial neuronal migration in the
developing cerebral cortex. Mol Cell Biol. 32:4297–4305. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rowland BD and Peeper DS: KLF4, p21 and
context-dependent opposing forces in cancer. Nat Rev Cancer.
6:11–23. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang B, Zhao MZ, Cui NP, Lin DD, Zhang AY,
Qin Y, Liu CY, Yan WT, Shi JH and Chen BP: Krüppel-like factor 4
induces apoptosis and inhibits tumorigenic progression in SK-BR-3
breast cancer cells. FEBS Open Bio. 5:147–154. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schulz WA and Hatina J: Epigenetic of
prostate cancer: Beyond DNA methylation. J Cell Mol Med.
10:100–125. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li H, Wang J, Xiao W, Xia D, Lang B, Wang
T, Guo X, Hu Z, Ye Z and Xu H: Epigenetic inactivation of KLF4 is
associated with urothelial cancer progression and early recurrence.
J Urol. 191:493–501. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sun H, Peng Z, Tang H, Xie D, Jia Z, Zhong
L, Zhao S, Ma Z, Gao Y, Zeng L, et al: Loss of KLF4 and
consequential downregulation of Smad7 exacerbate oncogenic TGF-β
signaling in and promote progression of hepatocellular carcinoma.
Oncogene. 36:2957–2968. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Park SY, Kim MJ, Park SA, Kim JS, Min KN,
Kim DK, Lim W, Nam JS and Sheen YY: Combinatorial TGF-β attenuation
with paclitaxel inhibits the epithelial-to-mesenchymal transition
and breast cancer stem like cells. Oncotarget. 6:37526–37543. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu YN, Abou-Kheir W, Yin JJ, Fang L,
Hynes P, Casey O, Hu D, Wan Y, Seng V, Sheppard-Tillman H, et al:
Critical and reciprocal regulation of KLF4 and SLUG in transforming
growth factor β-initiated prostate cancer epithelial-mesenchymal
transition. Mol Cell Biol. 32:941–953. 2012. View Article : Google Scholar : PubMed/NCBI
|
